Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs IDEXX Laboratories, Inc. — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.31 (market cap $40.01B), while IDEXX Laboratories, Inc. trades at $518.89 (market cap $40.43B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) and IDEXX Laboratories, Inc. are close in size by market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 1 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| HLN | IDXX | |
|---|---|---|
Market Cap | $40.01B | $40.43B |
Volume | 19,985,935 | 692,164 |
Sector | Health | Health |
52-Week High | $11.27 | $766.68 |
52-Week Low | $8.70 | $504.70 |
Typical Hold Time | 1 Days | 46 Days |
Enterprise Value | $49.79B | $41.32B |
Dividend Yield | 2.14% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Trailing returns across standard periods
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →